Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06121661 · ClinicalTrials.gov registry record · Phase 1

APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

A Phase 1 study of Wounds and Injuries, sponsored by Andrew Tomas Reisner.

Recruiting
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT06121661: Recruiting Phase 1 study of Wounds and Injuries, sponsored by Andrew Tomas Reisner.

NCT06121661 is a Phase 1 study of Wounds and Injuries that is actively recruiting participants, run by Andrew Tomas Reisner. The registered enrollment target is 20 participants, below the 503-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06121661, a Phase 1 study of Wounds and Injuries, is actively recruiting participants, sponsored by Andrew Tomas Reisner.

RECRUITING
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This is a pilot evaluation of the APPRAISE trauma decision-support software system ("the System"). The specific objections are as follows: 1. Evaluate the robustness of the System (i.e., whether the software performs in real-time in accordance with a priori technical specifications during real-time clinical use); 2. Evaluate whether the real-time display of the System causes distraction or confusion to clinicians treating the trauma patient such that its risks exceed its benefits; 3. Collect pilot data to allow for a statistical power analysis to design a future clinical trial evaluating efficacy.

Primary Outcome

Each time the software is used ("session"), a log file is generated. We will quantify how many sessions generate error messages or critical software errors.

Conditions Studied

Interventions

  • DEVICE APPRAISE Trauma Clinical Decision Support System

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-02-21
Est. Completion 2028-12-14
Phase Phase 1
Andrew Tomas Reisner

2 total trials

What NCT06121661 shows while recruiting

NCT06121661 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 503-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Wounds and Injuries appearing as the primary indexed condition, and to 1 intervention - of which APPRAISE Trauma Clinical Decision Support System is the first listed.

NCT06121661 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06121661 about?

NCT06121661 is a clinical study titled "APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System". This is a pilot evaluation of the APPRAISE trauma decision-support software system ("the System"). The specific objections are as follows: 1. Evaluate the robustness of the System (i.e., whether the software performs in real-time in accordance with a priori technical specifications during real-time...

What is the current status of trial NCT06121661?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2023-02-21. Estimated completion is 2028-12-14.

What conditions does trial NCT06121661 study?

This clinical trial studies the following conditions: Wounds and Injuries.

What interventions are being tested in trial NCT06121661?

The interventions under investigation include: APPRAISE Trauma Clinical Decision Support System (DEVICE).

Who is sponsoring clinical trial NCT06121661?

This trial is sponsored by Andrew Tomas Reisner, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06121661 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wounds and Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06121661's enrollment target sits among peer trials

20 26th of 27 higher than 2 of 27 other Wounds and Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Wounds and Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06121661, the US trial registry maintained by the National Library of Medicine. NCT06121661 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.